Chronic lymphocytic leukemia (B-CLL) occurring with human immunodeficiency virus (HIV) infection: implications.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0145-2126(03)00004-3PMID 12804644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics of indolent non‐hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection

  2002cited by this paper
• CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

  2002cited by this paper
• The Origin and Nature of the Chronic Lymphocytic Leukemia Lymphocyte

  2001cited by this paper
• Epstein-Barr virus: exploiting the immune system

  2001cited by this paper
• Hematologic Aspects of HIV/AIDS.

  2001influential reference
• CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.

  2001cited by this paper
• How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors.

  2001cited by this paper
• The epidemiology of acquired immunodeficiency syndrome malignancies.

  2000cited by this paper
• CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.

  2000cited by this paper
• Immunogenetic therapy for B-cell malignancies.

  2000cited by this paper
• CD95's deadly mission in the immune system

  2000cited by this paper
• Genomic aberrations and survival in chronic lymphocytic leukemia.

  2000cited by this paper
• The epidemiology of acquired immunodeficiency syndrome malignancies.

  2000cited by this paper
• Bryostatin and CD40‐ligand enhance apoptosis resistance and induce expression of cell survival genes in B‐cell chronic lymphocytic leukaemia

  1999cited by this paper
• Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

  1999cited by this paper
• Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

  1999cited by this paper
• Triggering of CD40 Antigen Inhibits Fludarabine-Induced Apoptosis in B Chronic Lymphocytic Leukemia Cells

  1998cited by this paper
• Molecular biology of chronic lymphocytic leukemia.

  1998cited by this paper
• Apoptosis in B-chronic lymphocytic leukaemia

  1998cited by this paper
• Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells.

  1998cited by this paper
• Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria.

  1998cited by this paper
• Molecular biology of chronic lymphocytic leukemia: implications for therapy.

  1998cited by this paper
• Role of the CD40 and CD95 (APO‐1/Fas) antigens in the apoptosis of human B‐cell malignancies

  1997cited by this paper
• Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.

  1995cited by this paper
• Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986).

  1988cited by this paper
• Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors.

  1987cited by this paper
• Epidemiological aspects of HTLV-III infection in Italy

  1985cited by this paper
• Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia.

  1983cited by this paper

• Chronic lymphocytic leukaemia trends and features at a tertiary hospital in South Africa (2011–2016)

  2021cites this paper
• HIV and Indolent Lymphoma

  2016cites this paper
• Treatment of chronic lymphocytic leukemia with bendamustine in an HIV-infected patient on antiretroviral therapy: a case report and review of the literature

  2015influential citation
• [Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia].

  2013influential citation
• Patogeneza, profilaktyka i leczenie infekcji u chorych na przewlekłą białaczkę limfocytową* Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia

  2013influential citation
• Prevalence of HIV seropositivity in patients with lymphoid malignancies in a tertiary centre in southern Nigeria.

  2009cites this paper
• Human immunodeficiency virus and chronic lymphocytic leukemia

  2009cites this paper
• Reconstitution of the T‐cell repertoire following treatment with alemtuzumab (anti‐CD52 monoclonal antibody) in patients with B‐cell chronic lymphocytic leukaemia

  2006cites this paper
• Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin.

  2006cites this paper